12th International Congress on Myeloproliferative Neoplasms

 

12th International Congress on Myeloproliferative Neoplasms
A

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP: Positive Effects on Blood Counts and Thrombosis Risk

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Alison Moliterno
By 12th International Congress on Myeloproliferative Neoplasms FEATURING Alison Moliterno
24 views
November 25, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Latest Advances in Myeloproliferative Neoplasms
19:58
12th International Congress on Myeloproliferative Neoplasms

How Should We Treat Children w/ MPN: No Guidelines on Cytoreduction …

Feat. N. Kucine
22:49

Old and New Myelofibrosis (MF) Classifications, When to Consider Tra…

12th International Congress on Myeloproliferative Neoplasms

H. Deeg

34 views
28:48

Introduction to Hypoxia and Erythropoiesis in the Context of High Al…

12th International Congress on Myeloproliferative Neoplasms

J. Prchal

32 views
26:03

Moving Beyond JAKi: Ruxolitinib Failure, Newly Approved and in Devel…

12th International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

114 views
28:30

Is There a Role of Transplantation for CML in the Era of TKIs?

12th International Congress on Myeloproliferative Neoplasms

K. Van Besien

21 views
16:32

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Ou…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

19 views
08:25

What is the Molecular Landscape of Blast Phase MPN and the Implicati…

12th International Congress on Myeloproliferative Neoplasms

O. Odenike

17 views
06:52

Targeting Dysregulated Iron Metabolism in Polycythemia Vera (PV) Pat…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

17 views
08:25

Therapeutic Options for Treating MPNs are Finally Expanding: Targeti…

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

165 views
11:27

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies …

12th International Congress on Myeloproliferative Neoplasms

R. Hoffman

21 views
17:00

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-F…

12th International Congress on Myeloproliferative Neoplasms

R. Silver

22 views
07:54

Update on Long Acting Interferons in MPN: Who Should Be Treated, Who…

12th International Congress on Myeloproliferative Neoplasms

H. Gisslinger

23 views
25:17

Wrangling the MPN-Related Symptom Burden: Specific Symptoms and Etio…

12th International Congress on Myeloproliferative Neoplasms

R. Scherber

169 views
26:23

Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subty…

12th International Congress on Myeloproliferative Neoplasms

A. Klion

34 views
30:14

Tales from the Clinic on Essential Thrombocytosis: No Therapy for As…

12th International Congress on Myeloproliferative Neoplasms

J. Spivak

51 views
13:55

Review of JAK2V617F and the Concept of the VAF

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

21 views
20:40

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP:…

12th International Congress on Myeloproliferative Neoplasms

A. Moliterno

24 views